Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Orphan Drugs Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Orphan Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Orphan Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Orphan Drugs market competition by top manufacturers/players, with Orphan Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Orphan Drugs for each application, including
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Orphan Drugs Sales Market Report 2017
1 Orphan Drugs Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs by Product Category
1.2.1 Global Orphan Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Orphan Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Oncology
1.2.4 Gastrointestinal
1.2.5 Pulmonary
1.2.6 Neurology
1.2.7 Hematology
1.2.8 Cardio-vascular
1.2.9 Metabolic disorders
1.2.10 Endocrinology
1.2.11 Infectious diseases
1.2.12 Others
1.3 Global Orphan Drugs Market by Application/End Users
1.3.1 Global Orphan Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Global Orphan Drugs Market by Region
1.4.1 Global Orphan Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Orphan Drugs Status and Prospect (2012-2022)
1.4.3 China Orphan Drugs Status and Prospect (2012-2022)
1.4.4 Europe Orphan Drugs Status and Prospect (2012-2022)
1.4.5 Japan Orphan Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Orphan Drugs Status and Prospect (2012-2022)
1.4.7 India Orphan Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Orphan Drugs (2012-2022)
1.5.1 Global Orphan Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Orphan Drugs Revenue and Growth Rate (2012-2022)

2 Global Orphan Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Orphan Drugs Market Competition by Players/Suppliers
2.1.1 Global Orphan Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Orphan Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Orphan Drugs (Volume and Value) by Type
2.2.1 Global Orphan Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Orphan Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Orphan Drugs (Volume and Value) by Region
2.3.1 Global Orphan Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Orphan Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Orphan Drugs (Volume) by Application

3 United States Orphan Drugs (Volume, Value and Sales Price)
3.1 United States Orphan Drugs Sales and Value (2012-2017)
3.1.1 United States Orphan Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Orphan Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Orphan Drugs Sales Price Trend (2012-2017)
3.2 United States Orphan Drugs Sales Volume and Market Share by Players
3.3 United States Orphan Drugs Sales Volume and Market Share by Type
3.4 United States Orphan Drugs Sales Volume and Market Share by Application

4 China Orphan Drugs (Volume, Value and Sales Price)
4.1 China Orphan Drugs Sales and Value (2012-2017)
4.1.1 China Orphan Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Orphan Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Orphan Drugs Sales Price Trend (2012-2017)
4.2 China Orphan Drugs Sales Volume and Market Share by Players
4.3 China Orphan Drugs Sales Volume and Market Share by Type
4.4 China Orphan Drugs Sales Volume and Market Share by Application

5 Europe Orphan Drugs (Volume, Value and Sales Price)
5.1 Europe Orphan Drugs Sales and Value (2012-2017)
5.1.1 Europe Orphan Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Orphan Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Orphan Drugs Sales Price Trend (2012-2017)
5.2 Europe Orphan Drugs Sales Volume and Market Share by Players
5.3 Europe Orphan Drugs Sales Volume and Market Share by Type
5.4 Europe Orphan Drugs Sales Volume and Market Share by Application

6 Japan Orphan Drugs (Volume, Value and Sales Price)
6.1 Japan Orphan Drugs Sales and Value (2012-2017)
6.1.1 Japan Orphan Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Orphan Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Orphan Drugs Sales Price Trend (2012-2017)
6.2 Japan Orphan Drugs Sales Volume and Market Share by Players
6.3 Japan Orphan Drugs Sales Volume and Market Share by Type
6.4 Japan Orphan Drugs Sales Volume and Market Share by Application

7 Southeast Asia Orphan Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Orphan Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Orphan Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Orphan Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Orphan Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Orphan Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Orphan Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Orphan Drugs Sales Volume and Market Share by Application

8 India Orphan Drugs (Volume, Value and Sales Price)
8.1 India Orphan Drugs Sales and Value (2012-2017)
8.1.1 India Orphan Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Orphan Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Orphan Drugs Sales Price Trend (2012-2017)
8.2 India Orphan Drugs Sales Volume and Market Share by Players
8.3 India Orphan Drugs Sales Volume and Market Share by Type
8.4 India Orphan Drugs Sales Volume and Market Share by Application

9 Global Orphan Drugs Players/Suppliers Profiles and Sales Data
9.1 Novartis AG
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Orphan Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novartis AG Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb Company
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Orphan Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Celgene Corporation
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Orphan Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Celgene Corporation Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Orphan Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Pfizer, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Orphan Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Pfizer, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Sanofi S.A.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Orphan Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Sanofi S.A. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Alexion Pharmaceuticals, Inc.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Orphan Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Eli Lilly and Company
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Orphan Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Novo Nordisk A/S
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Orphan Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Novo Nordisk A/S Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 AstraZeneca
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Orphan Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 AstraZeneca Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Eisai Co., Ltd.
9.12 Daiichi Sankyo Company Limited
9.13 Bayer AG
9.14 GlaxoSmithKline
9.15 Merck & Co., Inc.
9.16 Johnson & Johnson
9.17 Biogen, Inc.
9.18 Shire
9.19 Amgen, Inc.

10 Orphan Drugs Maufacturing Cost Analysis
10.1 Orphan Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Orphan Drugs
10.3 Manufacturing Process Analysis of Orphan Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Orphan Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Orphan Drugs Market Forecast (2017-2022)
14.1 Global Orphan Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Orphan Drugs Price and Trend Forecast (2017-2022)
14.2 Global Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Orphan Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Orphan Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Orphan Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Orphan Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Orphan Drugs Price Forecast by Type (2017-2022)
14.4 Global Orphan Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37983

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 114

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)